These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 19808356
1. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. Theis JL, Bos JM, Theis JD, Miller DV, Dearani JA, Schaff HV, Gersh BJ, Ommen SR, Moss RL, Ackerman MJ. Circ Heart Fail; 2009 Jul; 2(4):325-33. PubMed ID: 19808356 [Abstract] [Full Text] [Related]
2. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, Sadayappan S. PLoS One; 2017 Jul; 12(11):e0187948. PubMed ID: 29121657 [Abstract] [Full Text] [Related]
3. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. Roncarati R, Latronico MV, Musumeci B, Aurino S, Torella A, Bang ML, Jotti GS, Puca AA, Volpe M, Nigro V, Autore C, Condorelli G. J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287 [Abstract] [Full Text] [Related]
4. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, Regan JA, Boontje N, Ten Cate FJ, Germans T, Carrier L, Sadayappan S, van Slegtenhorst MA, Zaremba R, Foster DB, Murphy AM, Poggesi C, Dos Remedios C, Stienen GJ, Ho CY, Michels M, van der Velden J. Circ Res; 2013 May 24; 112(11):1491-505. PubMed ID: 23508784 [Abstract] [Full Text] [Related]
5. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy. Chida A, Inai K, Sato H, Shimada E, Nishizawa T, Shimada M, Furutani M, Furutani Y, Kawamura Y, Sugimoto M, Ishihara J, Fujiwara M, Soga T, Kawana M, Fuji S, Tateno S, Kuraishi K, Kogaki S, Nishimura M, Ayusawa M, Ichida F, Yamazawa H, Matsuoka R, Nonoyama S, Nakanishi T. Heart Vessels; 2017 Jun 24; 32(6):700-707. PubMed ID: 27885498 [Abstract] [Full Text] [Related]
6. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Mori AA, Castro LR, Bortolin RH, Bastos GM, Oliveira VF, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Pachón-Mateos JC, Correia EB, Sousa AGMR, Brión M, Carracedo A, Hirata RDC, Hirata MH. Forensic Sci Int Genet; 2021 May 24; 52():102478. PubMed ID: 33588347 [Abstract] [Full Text] [Related]
7. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Witjas-Paalberends ER, Güçlü A, Germans T, Knaapen P, Harms HJ, Vermeer AM, Christiaans I, Wilde AA, Dos Remedios C, Lammertsma AA, van Rossum AC, Stienen GJ, van Slegtenhorst M, Schinkel AF, Michels M, Ho CY, Poggesi C, van der Velden J. Cardiovasc Res; 2014 Jul 15; 103(2):248-57. PubMed ID: 24835277 [Abstract] [Full Text] [Related]
8. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy. Velicki L, Jakovljevic DG, Preveden A, Golubovic M, Bjelobrk M, Ilic A, Stojsic S, Barlocco F, Tafelmeier M, Okwose N, Tesic M, Brennan P, Popovic D, Ristic A, MacGowan GA, Filipovic N, Maier LS, Olivotto I. BMC Cardiovasc Disord; 2020 Dec 09; 20(1):516. PubMed ID: 33297970 [Abstract] [Full Text] [Related]
9. Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry. Höller V, Seebacher H, Zach D, Schwegel N, Ablasser K, Kolesnik E, Gollmer J, Waltl G, Rainer PP, Verheyen S, Zirlik A, Verheyen N. Genes (Basel); 2021 Sep 23; 12(10):. PubMed ID: 34680864 [Abstract] [Full Text] [Related]
11. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B. Clin Res Cardiol; 2018 Jan 23; 107(1):30-41. PubMed ID: 28840316 [Abstract] [Full Text] [Related]
12. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy. Núñez L, Gimeno-Blanes JR, Rodríguez-García MI, Monserrat L, Zorio E, Coats C, McGregor CG, Hernandez del Rincón JP, Castro-Beiras A, Hermida-Prieto M. Circ J; 2013 Jan 23; 77(9):2358-65. PubMed ID: 23782526 [Abstract] [Full Text] [Related]
13. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation. Guo G, Wang L, Li X, Fu W, Cao J, Zhang J, Liu Y, Liu M, Wang M, Zhao G, Zhao X, Zhou Y, Niu S, Liu G, Zhang Y, Dong J, Tao H, Zhao X. Cell Calcium; 2024 Jan 23; 117():102822. PubMed ID: 38101154 [Abstract] [Full Text] [Related]
14. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy. O'Leary TS, Snyder J, Sadayappan S, Day SM, Previs MJ. J Mol Cell Cardiol; 2019 Feb 23; 127():165-173. PubMed ID: 30550750 [Abstract] [Full Text] [Related]
17. [The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy]. WANG H, ZOU YB, WANG JZ, SONG L, SUN K, SONG XD, WANG XJ, ZHANG CN, HUI RT. Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec 23; 36(12):1059-62. PubMed ID: 19134269 [Abstract] [Full Text] [Related]